Drugs / Xaliproden
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00603577 | Jan 2008 → Nov 2009 | colorectal neoplasm | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00305188 | Dec 2005 → Oct 2009 | colorectal carcinoma, metastatic neoplasm | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00104013 | Nov 2003 → Nov 2007 | Alzheimer disease | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00103649 | Nov 2003 → Oct 2007 | Alzheimer disease | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00272051 | Jul 2002 → May 2004 | colorectal carcinoma, metastatic neoplasm | Sanofi | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | xaliproden | “Purpose of the trial is to evaluate the efficacy of Xaliproden in reducing the neurotoxicity of the Oxaliplatin and 5-FU/LV chemotherapy” NCT00272051 ↗ |
| Known as | SR 57746 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1512580 ↗ |
| Known as | SR57746A | “xaliproden (SR57746A)” NCT00104013 ↗ |
| Known as | xaliproden hydrochloride | “To assess the effect of xaliproden hydrochloride (xaliproden) 1 mg per oral daily on the rate of complete resolution of peripheral sensory neuropathy (PSN) at 6 months,...” NCT00603577 ↗ |
| Known as | Xaliprodene | ChEMBL registry synonym — accepted as the source's own label CHEMBL1512580 ↗ |
| Known as | Xaliprodeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL1512580 ↗ |
| Action | Activate | “Serotonin 1a (5-HT1a) receptor agonist” CHEMBL1512580 ↗ |
| Modality | Small molecule | — CHEMBL1512580 ↗ |
| Route | Oral | “The patients participating in this study will take orally once daily xaliproden or placebo (inactive substance pill).” NCT00103649 ↗ |
| Target | HTR1A | “Serotonin 1a (5-HT1a) receptor agonist” CHEMBL1512580 ↗ |